Canaccord raised the firm’s price target on AdaptHealth (AHCO) to $15 from $14. The firm raised its target and estimates to reflect updated 2026 estimates. They believe that there is the opportunity for multiple expansion as CEO Suzanne Foster’s initiative to standardize the company’s field operating model and organization structure to improve patient service and financial performance takes hold.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHCO: